Anderson Sousa Martins-da-Silva

Anderson Sousa Martins-da-Silva

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in CNS & Neurological Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
Anderson Sousa Martins-da-SilvaAnderson Sousa Martins-da-Silva
Anderson Sousa Martins-da-Silva
FMFelipe Maraucci Ribeiro de Mendonça
Felipe Maraucci Ribeiro de Mendonça
GMGiulia Paulo Rossi Ribeiro de Mendonça
Giulia Paulo Rossi Ribeiro de Mendonça
LSLaura Costa Souza
Laura Costa Souza
LGLucas Pequeno Galvão
Lucas Pequeno Galvão
JCJoão Mauricio Castaldelli-Maia
João Mauricio Castaldelli-Maia
Background: Insomnia, defined as a difficulty in initiating or maintaining sleep, is a relevant medical issue. Benzodiazepines (BZDs) are commonly prescribed to treat insomnia. Two phases characterize human sleep structure: sleep with Non-Rapid Eye Movement (NREM) and sleep with Rapid Eye Movement (REM). Physiological sleep includes NREM and REM phases in a continuous cycle known as “Sleep Architecture.” Objective: This systematic review summarizes the studies that have investigated effects of BZDs on Sleep Architecture. Methods: The articles selection included human clinical trials (in English, Portuguese, or Spanish) only, specifically focused on BZDs effects on sleep architecture. PubMed, BVS, and Google Scholar databases were searched. Results: Findings on BZDs effects on sleep architecture confirm an increase in stage 2 of NREM sleep and a decrease in time of stages 3 and 4 of NREM sleep with a reduction in time of REM sleep during the nocturnal sleep. Conclusion: Variations in NREM and REM sleep may lead to deficits in concentration and working memory and weight gain. The increase in stage 2 of NREM sleep may lead to a subjective improvement of sleep quality with no awakenings. BZDz should be prescribed with zeal and professional judgment. These patients should be closely monitored for possible long-term side effects.

2 January 2022 in International Review of Psychiatry
Verified
Journal Article
Closed access
Anderson Sousa Martins-da-SilvaAnderson Sousa Martins-da-Silva
Anderson Sousa Martins-da-Silva
JTJulio Torales
Julio Torales
RBRuth Francyelle Vieira Becker
Ruth Francyelle Vieira Becker
HMHelena F. Moura
Helena F. Moura
MCMarcela Waisman Campos
Marcela Waisman Campos
JCJoão Mauricio Castaldelli-Maia
João Mauricio Castaldelli-Maia
Tobacco use is associated with an annual global economic cost of two trillion dollars and mortality of half of its regular users. Tobacco leaf cultivation is the starting point of the tobacco cycle. Tobacco farming employs millions of small-scale tobacco farmers around the globe, most of whom are out growers who rely on the tobacco industry. This paper aims to map the regions of greatest tobacco production globally (i.e., the US, Brazil, China, Indonesia, India, and Zambia) and tobacco use rates in these locations. Smoking rates were higher in those areas, except for India, where important population subgroups reported an upward trend for tobacco smoking. In general, there was a relationship between tobacco farming and tobacco smoking. Tobacco farming may lead to a higher risk of tobacco use and lower adherence to tobacco control policies. Therefore, promoting viable alternative livelihoods for tobacco farmers must have dual benefits. Additionally, specific health prevention policies might be necessary for those populations reporting higher tobacco use and lower perception of tobacco-related health risks.

12 July 2022 in Heliyon
Verified
Journal Article
Open access
MCMarina Junqueira Clemente
Marina Junqueira Clemente
Anderson Sousa Martins-da-SilvaAnderson Sousa Martins-da-Silva
Anderson Sousa Martins-da-Silva
MPMaria Olivia Pozzolo Pedro
Maria Olivia Pozzolo Pedro
HPHenrique Soares Paiva
Henrique Soares Paiva
CPCintia de Azevedo Marques Périco
Cintia de Azevedo Marques Périco
JCJoão Mauricio Castaldelli-Maia
João Mauricio Castaldelli-Maia
There is a relative dearth of research on Obsessive-Compulsive Personality Disorder (OCPD), even if it has been recognized for over 100 years. Thus, the present study aims to review the worldwide prevalence of OCPD in different populations. The search was conducted employing the PubMed database of the US National Library of Medicine and Biblioteca Virtual em Saúde (BVS) to detect available studies showing OCPD prevalence rates. All the prevalence rates were extracted and aggregated through random-effects models. Meta-regression and sensitivity analyses were performed. The final sample was composed of 46 articles, including 89,264 individuals. We found that OCPD reports a high prevalence rate, with 6.5% (95%CI = 4.3–9.1%), and reaching even higher among psychiatric and clinical patient population. OCPD has presented stable prevalence rates worldwide throughout the past 28 years. There was no gender-related effect, but OCPD prevalence rates may decrease with age increase. There is a need to investigate personality disorders epidemiology based on the recently updated classification systems (i.e., DSM-5 and ICD-11). The present meta-analysis may suggest that the current diagnostic tools may detect OCPD in a cross-sectional assessment but not throughout the life of the person.

1 January 2023 in Revista Paulista de Pediatria
Verified
Journal Article
Open access
LSLaura Costa Souza
Laura Costa Souza
LGLucas Pequeno Galvão
Lucas Pequeno Galvão
HPHenrique Soares Paiva
Henrique Soares Paiva
CPCintia Azevedo-Marques Perico
Cintia Azevedo-Marques Perico
AVAntonio Ventriglio
Antonio Ventriglio
Anderson Sousa Martins-da-SilvaAnderson Sousa Martins-da-Silva
Anderson Sousa Martins-da-Silva
Objective: This study aimed to analyze the effect of major depressive disorder (MDD) as a risk factor for suicidal ideation in individuals whose ages varied from 11 to 24 years and who were attending educational institutions. Data source: A systematic review was carried out by searching in PubMed and Biblioteca Virtual em Saúde (BVS). Original studies conducted in educational institutions, including individuals whose age varied from 11 to 24 years, in English, Spanish, or Portuguese were included. Data synthesis: Eight studies were selected for the meta-analysis, including 35,443 youths, with an average age of 16.8 years, predominantly female (51.2%), and from middle-income Asian countries (91.6%). An odds ratio of MDD of 3.89 (95%CI 2.46–6.17) for suicide ideation in youth was found. Subgroup analysis showed higher effects in Asia (OR=4.71; 95%CI 3.22–6.89) than Americas (OR=1.71; 95%CI 1.44–2.03). The meta-regression model indicated that younger adolescents (coef=-0.63; 95%CI 1.09–-0.18; p<0.01) and older studies (coef=-0.23; 95%CI 0.039–-0.08; p<0.01) presented higher effects of MDD on suicidal ideation. Conclusions: Early detection and treatment of MDD in youth patients are of utmost importance for preventing suicidal ideation. Educational institutions could play an important role in the early detection and intervention.

15 August 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
MMMatheus Cheibub David Marin
Matheus Cheibub David Marin
Maria Olivia Pozzolo PedroMaria Olivia Pozzolo Pedro
Maria Olivia Pozzolo Pedro
GPGiuliana Perrotte
Giuliana Perrotte
Anderson Sousa Martins-da-SilvaAnderson Sousa Martins-da-Silva
Anderson Sousa Martins-da-Silva
DLDângela Layne Silva Lassi
Dângela Layne Silva Lassi
JCJoão Mauricio Castaldelli-Maia
João Mauricio Castaldelli-Maia
(1) Background: The treatment of substance addiction is challenging and has persisted for decades, with only a few therapeutic options. Although there are some recommendations for specific treatments for Alcohol Use Disorder (AUD), there is no specific medication used to treat alcohol cravings, which could benefit millions of patients that are suffering from alcoholism. Cravings, or the urge to use drugs, refer to the desire to experience the effects of a previously experienced psychoactive substance. (2) Methods: We included original studies of alcohol abuse or dependence extracted from a controlled, blind, pharmacological treatment study which presented measures and outcomes related to alcohol cravings. (3) Results: Specific drugs used for the treatment of alcoholism, such as Naltrexone and Acamprosate, have had the best results in relieving craving symptoms, as well as promoting abstinence. Baclofen and anticonvulsants such as Gabapentin and Topiramate have shown good results in promoting abstinence and the cessation of cravings. (4) Conclusions: Specific drugs used for the treatment of alcoholism to obtain the best results can be considered the gold standard for promoting abstinence and relieving cravings. Anticonvulsants and Baclofen also had good results, with these medications being considered as second-line ones. Varenicline is an option for alcohol dependents who also concomitantly ingest tobacco.

27 May 2020 in International Review of Psychiatry
Verified
Journal Article
Closed access
GBGuilherme Passamani Borges
Guilherme Passamani Borges
JTJoão Henrique Almeida Tonon
João Henrique Almeida Tonon
PZPablo Andres Alves da Silva Zunini
Pablo Andres Alves da Silva Zunini
Anderson Sousa Martins-da-SilvaAnderson Sousa Martins-da-Silva
Anderson Sousa Martins-da-Silva
MGMarcelo de Freitas Valeiro Garcia
Marcelo de Freitas Valeiro Garcia
JCJoão Mauricio Castaldelli-Maia
João Mauricio Castaldelli-Maia
Soldier’s Heart (SH) is a former medical diagnosis, rarely mentioned nowadays, presented under several other names. Considering the controversy regarding the removal of Soldier’s Heart diagnosis from DSM-5, this study aimed to conduct a systematic review to evaluate its usage in the clinical practice. Information on diagnosis, military stress, heart rate variability, treatment, and prognosis were collected from 19 studies included after a systematic literature search. Considering the lack of adequate use of Soldier’s Heart diagnosis and the diagnostic overlapping with other conditions, the present systematic review supports the inclusion of Soldier’s Heart under the umbrella of posttraumatic stress disorders (PTSDs). This proposal is also in line with the conception that physical symptoms are relevant features often associated with generalized anxiety disorder and PTSD. Also, it will be described the higher prevalence of cardiological comorbidities in SH and possible cardiological consequences. Pharmacotherapy based on benzodiazepines and beta-blockers, as well as biofeedback and mindfulness techniques are considered to be useful treatment options. Further studies are needed to better define psychopathological domains of this syndrome and possible novel treatment targets.